Sign in

You're signed outSign in or to get full access.

Elizabeth J. Boland

Chief Financial Officer at BRIGHT HORIZONS FAMILY SOLUTIONSBRIGHT HORIZONS FAMILY SOLUTIONS
Executive

About Elizabeth J. Boland

Elizabeth J. “Liz” Boland is Chief Financial Officer of Bright Horizons, a role she has held since June 1999 (joined 1997; previously SVP Finance post-merger in 1998–1999). She is 65 years old as of December 31, 2024, and has more than 25 years as BFAM’s CFO, with prior experience at Price Waterhouse and CFO/VP-Finance roles at other companies . Company performance under her finance leadership in 2024 included 11% revenue growth (to $2.686B) and Adjusted EBITDA of ~$409.3M, alongside net income of ~$140.2M; back-up care and education services complemented the core center-based business . One-year TSR for 2024 was 17.61% (3-year: -4.16%; 5-year: -5.92%), broadly in line with relevant indices on a 1-year basis .

Past Roles

OrganizationRoleYearsStrategic impact
Bright Horizons Family SolutionsChief Financial Officer1999–presentLong-tenured CFO overseeing capital allocation, financing, M&A integration, and reporting through cycles
Bright Horizons Family SolutionsTreasurer (additional responsibility)2016–2020; 2023–July 2024Cash, liquidity and treasury oversight through rising-rate environment
Bright Horizons Family SolutionsSenior Vice President, Finance (post-merger)1998–1999Finance leadership post-merger integration (BH + Corporate Family Solutions)
Various companies (pre-BFAM)CFO and VP-Finance rolesPre-1997Finance leadership at prior firms
Price Waterhouse (Boston)Audit staff → Senior audit manager1981–1990External audit, controls and reporting foundation

External Roles

OrganizationRoleYearsNotes
The Children’s Place (PLCE)Director; Audit Committee (2019–2023); Compensation Committee (2023–2024)2019–Feb 2024Public company board, finance and comp oversight experience

Fixed Compensation

Metric202220232024
Base salary ($)373,437 400,000 414,000
Target annual bonus (% of salary)100% 100% 100%
Bonus paid under annual bonus plan ($, individual performance half)186,718 200,000 207,000
Non‑equity incentive plan payout ($, corporate performance half)37,344 127,200 207,000

Notes:

  • Target annual bonus for 2024 remained 100% of salary; all NEOs earned 100% of salary total bonus after a 2.5% discretionary alignment adjustment; see “Performance Compensation” for detail .

Performance Compensation

Annual cash incentive (2024 design and outcome)

ComponentWeightTargetActual/ScorePayout contribution
Individual goals50%QualitativeAchieved 100% of individual half 50% of salary × 100% = 50% of salary
Adjusted EBITDA25%$421.9M $409.29M; score 88.0% of sub-target factor Included in 47.5% corporate half result
Adjusted EPS25%$3.45 $3.47; score 102.2% of sub-target factor Included in 47.5% corporate half result
Corporate performance (weighted)50%Earned 47.5% of salary (of the 50% corporate half) 47.5% of salary
Discretionary alignment+2.5% to align with Home Team 100% payout +2.5% of salary
Total bonus paid100%100% of salary100% of salary 100% of salary

Design notes: Corporate metrics equally weighted (Adj. EBITDA and Adj. EPS); a 3x cap applies on the corporate performance portion; EBITDA/EPS definitions are non‑GAAP as disclosed .

Long-term equity incentive (LTIP) structure

  • Mix: 50% time-based RSUs (3-year cliff); 25% PRSUs (3-year cliff, vest based on 3-year average annual Adjusted EBITDA growth); 25% stock options (3-year ratable vest) .
  • PRSU payout grid: 0% below threshold; 50% at threshold; 100% at target; 200% at max, based on average annual Adjusted EBITDA growth over the period .

2024 LTIP grants (granted March 4, 2024):

InstrumentTarget $Shares/OptionsPrice/StrikeVestingPerformance metric
RSU550,000 4,756 Cliff vest 3/4/2027 (3 years) Time-based
PRSU (target)275,000 2,378 Cliff vest 3/4/2027 (3-year performance) 3-year avg annual Adj. EBITDA growth
Stock options275,000 5,356 $115.65 1/3 on each anniversary through 3/4/2027 Share price appreciation

Outstanding option snapshot (as of 12/31/2024):

Grant dateExercisableUnexercisableExercise priceExpiration
2/25/20196,510 $122.44 2/25/2026
2/26/20212,034 1,356 $159.66 2/26/2028
2/25/202210,440 $128.81 2/25/2029
2/24/20235,512 $77.99 2/24/2033
3/4/20245,356 $115.65 3/4/2034

2024 realized transactions:

  • Option exercises: 5,500 options exercised on 8/7/2024 via net settlement; value realized $240,153 (after withholding shares for taxes/exercise) .

Equity Ownership & Alignment

Item (as of Apr 10, 2025 unless noted)Detail
Total beneficial ownership87,597 shares (includes derivatives within 60 days)
Ownership % of outstanding<1%
Options exercisable within 60 days19,967 shares via options (within 60 days)
Unvested RSUs (scheduled vest dates)7,052 (vest 2/24/2026); 4,756 (vest 3/4/2027); 4,224 (vest 3/5/2028)
Unvested PRSUs (performance-contingent)3,526 (to 2/24/2026); 2,378 (to 3/4/2027); 2,112 (to 3/5/2028) at target, subject to performance
Anti-hedging/pledgingHedging and pledging prohibited by policy
Ownership guidelinesExecutives: 3x salary; as of Dec 31, 2024, NEOs with requisite tenure met or exceeded guideline

Implications for supply/demand around stock:

  • Upcoming RSU/PRSU settlements in 2026–2028 could create periodic sellable supply; options continue to vest through 2027 under 2024–2021 grants .
  • Policy restrictions (no pledging/hedging) and ownership guideline compliance indicate alignment and reduced governance risk .

Employment Terms

Severance and change‑of‑control (COC) summary (per current agreements):

  • COC vesting: All unvested options vest immediately prior to a change of control. RSUs/PRSUs fully vest on a COC if employed >2 years; if employed <2 years, RSUs/PRSUs vest on termination without cause/for good reason within 12 months post‑COC (double‑trigger). Purchased restricted stock vests on COC .
  • COC termination (Protection Period: 24 months): Pro‑rata bonus for year of termination; salary+bonus continuation equal to total base salary and cash bonus compensation for the prior two years paid over up to two years; 24 months of medical benefits continuation or cash equivalent .
  • Non‑COC termination (without cause/for good reason): 1 year of salary continuation and pro‑rata bonus; equity treatment per award terms (PRSU pro‑rata at target) .
  • Restrictive covenants: Confidentiality; non‑compete, non‑solicit, and non‑hire during severance payment period; release required .

Estimated payments (if triggering event on 12/31/2024):

ScenarioPro‑rata bonusSalary/bonus continuationMedical continuationEquity acceleration
Termination without cause/for good reason + COC$414,000 $1,555,200 $42,434 $2,614,523
Termination without cause/for good reason (no COC)$414,000 $414,000 $348,439
Death/Disability$414,000 $818,462
Change of control (equity only)$2,614,523

Investment Implications

  • Pay-for-performance structure: 2024 bonus tied 50% to corporate non‑GAAP metrics (Adj. EBITDA/EPS) and 50% to individual goals; long-term equity is majority time-vested RSUs with performance PRSUs keyed to multi‑year EBITDA growth; this creates partial cyclical sensitivity (EPS/EBITDA) with an additional time-based retention element .
  • Selling pressure watchpoints: Scheduled RSU/PRSU settlements in 2026–2028 (7,052/4,756/4,224 RSUs; 3,526/2,378/2,112 PRSUs at target) and option vesting through 2027 may introduce periodic supply; Boland net‑settled and exercised 5,500 options in 2024, signaling periodic liquidity activity but within normal patterns for long‑tenured executives .
  • Alignment and governance: Anti‑hedging/pledging policy, robust clawback, 3x salary ownership guideline (met), no tax gross‑ups, no option repricing, and strong 2024 say‑on‑pay support (~94%) are positive governance signals that reduce headline risk around compensation .
  • Retention risk: COC economics are moderate (salary+bonus over two years; healthcare continuation; equity vesting mechanics with service requirements for RSUs/PRSUs <2 years), with restrictive covenants during severance—adequate retention but not excessive golden parachute exposure .
  • Track record/context: 2024 revenue growth of 11% to $2.686B with segment contribution led by $1.962B center-based care and $610M back-up care; Adjusted EBITDA ~$409.3M; 1‑year TSR 17.61%. The comp mix tied to EBITDA/EPS aligns to value creation levers BFAM emphasizes (occupancy/utilization, pricing, mix, and cost discipline) .

Additional Reference Tables

Multi‑year Summary Compensation (NEO disclosure)

YearSalary ($)Bonus ($)Stock awards ($)Option awards ($)Non‑equity incentive ($)All other comp ($)Total ($)
2024414,000 207,000 825,047 274,977 207,000 4,409 1,932,433
2023400,000 200,000 824,978 274,995 127,200 5,440 1,832,613
2022373,437 186,718 651,779 478,872 37,344 5,905 1,734,055

2024 company performance context

Metric (FY2024)Value
Revenue$2,686,013k
Adjusted EBITDA$409,286k
Net income$140,191k
Revenue by segmentCenter-based: $1,961,785k; Back-up care: $610,112k; Educational advisory: $114,116k
1‑year TSR (2024)17.61%

Risk Indicators & Other Notes

  • Clawback policy aligned to NYSE/SEC rules (mandatory recoupment upon restatement) .
  • Insider-trading policy prohibits hedging/pledging; equity award timing avoids MNPI windows .
  • No reportable related‑party transactions in 2024 .
  • Compensation Committee members and independence (Jordan Hitch Chair; Lawrence Alleva; Joshua Bekenstein) .

Say‑on‑Pay & Shareholder Feedback

  • 2024 say‑on‑pay received approximately 94% support, reinforcing investor acceptance of compensation design and outcomes; off‑season engagement covered executive compensation among other topics .

Expertise & Qualifications

  • Deep finance and audit background (Price Waterhouse senior audit manager; multiple prior CFO/VP‑Finance roles), public board service (PLCE) and two stints as BFAM Treasurer; extensive tenure provides continuity across cycles, capital markets transactions, and credit agreements (e.g., 2025 term loan amendment signage) .